Study leader professor Johann de Bono said: “At the moment assess in the clinic how men with advanced prostate cancer are responding to their treatment. Measuring the levels of circulating tumour cells in blood samples could be a relatively quick and effective way to test men in the ...
A method for aiding in the detection of prostate cancer in male human patients, comprising the steps of: (a) measuring the amount of complexed prostate specific antigen (cPSA) or PSA- ACT in a blood sample obtained from such patient, and (b) determining if the patient's cPSA or PSA-ACT...
You probably had a blood test to check your levels of PSA -- a protein called prostate-specific antigen -- before your doctor told you that you haveprostate cancer. You'll still get those tests now that your cancer has spread beyond your prostate. ...
Prostate cancer, disease characterized by uncontrolled growth of cells within the prostate gland. Prostate cancer is a frequently diagnosed cancer among males. Learn more about the causes, symptoms, and treatment of prostate cancer.
The prostate-specific antigen (PSA) test is used to measure blood PSA levels and help detect prostate cancer or other prostate abnormalities.
A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer.
There is evidence that high blood level of DPA that is linked with reduced total prostate cancer risk and elevated blood levels of fish oils, EPA, and DHA is associated with high-grade prostate tumor, but careful interpretation is needed due to intricate details involved in prostate ...
Mitchell believes the technique will be transformative in providing improved cancer diagnostics that can both predict treatment outcomes and monitor patient responses to therapy. In a large retrospective study of blood samples, the researchers showed that the method, called a "liquid biopsy," could acc...
Gleason grading of tumor biopses is the only method to distinguish clinically significant prostate cancer. Local cancer is usually symptomless, and men would benefit from functional screening. The aim of improving blood test diagnostics is to find those for whom it is profitable on the basis of...
Prostate cancer patients whose tumors contain a shortened protein called AR-V7, which can be detected in the blood, are less likely to respond to two widely used drugs for metastatic prostate cancer, according to results of a study led by researchers at